Swiss National Bank
ACH

Swiss National Bank’s Accendra Health ACH Stock Holding History

Swiss National Bank’s Portfolio ACH Stock Details ACH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-148,500
Closed -$713K – 2355
2025
Q3 		$713K Buy
148,500
+6,500
+5% +$41.4K ﹤0.01% 2255
2025
Q2 		$1.29M Hold
142,000
– – ﹤0.01% 2020
2025
Q1 		$1.28M Buy
142,000
+5,500
+4% +$58.1K ﹤0.01% 2016
2024
Q4 		$1.78M Sell
136,500
-5,500
-4% -$73.3K ﹤0.01% 1924
2024
Q3 		$2.23M Sell
142,000
-1,100
-0.8% -$16.7K ﹤0.01% 1800
2024
Q2 		$1.93M Buy
143,100
+7,200
+5% +$147K ﹤0.01% 1833
2024
Q1 		$3.77M Sell
135,900
-7,400
-5% -$164K ﹤0.01% 1476
2023
Q4 		$2.76M Sell
143,300
-15,800
-10% -$286K ﹤0.01% 1663
2023
Q3 		$2.57M Buy
159,100
+1,500
+1% +$26.6K ﹤0.01% 1683
2023
Q2 		$3M Buy
157,600
+1,300
+0.8% +$23.2K ﹤0.01% 1621
2023
Q1 		$2.27M Sell
156,300
-18,600
-11% -$333K ﹤0.01% 1769
2022
Q4 		$3.42M Buy
174,900
+3,400
+2% +$66.3K ﹤0.01% 1545
2022
Q3 		$4.13M Buy
171,500
+2,000
+1% +$61.6K ﹤0.01% 1389
2022
Q2 		$5.33M Hold
169,500
– – ﹤0.01% 1280
2022
Q1 		$7.46M Buy
169,500
+12,200
+8% +$524K ﹤0.01% 1196
2021
Q4 		$6.84M Sell
157,300
-400
-0.3% -$15.7K ﹤0.01% 1253
2021
Q3 		$4.93M Buy
157,700
+3,800
+2% +$150K ﹤0.01% 1470
2021
Q2 		$6.51M Sell
153,900
-14,000
-8% -$545K ﹤0.01% 1300
2021
Q1 		$6.31M Buy
167,900
+1,700
+1% +$53.2K ﹤0.01% 1310
2020
Q4 		$4.5M Buy
166,200
+30,500
+22% +$785K ﹤0.01% 1433
2020
Q3 		$3.41M Buy
135,700
+2,000
+1% +$29.2K ﹤0.01% 1424
2020
Q2 		$1.02M Buy
133,700
+13,200
+11% +$96.6K ﹤0.01% 2088
2020
Q1 		$1.1M Hold
120,500
– – ﹤0.01% 1777
2019
Q4 		$623K Buy
+120,500
New +$774K ﹤0.01% 2354
2019
Q2 		– Sell
-110,200
Closed -$452K – 2568
2019
Q1 		$452K Hold
110,200
– – ﹤0.01% 2392
2018
Q4 		$698K Buy
110,200
+3,600
+3% +$37.4K ﹤0.01% 2204
2018
Q3 		$1.76M Hold
106,600
– – ﹤0.01% 1798
2018
Q2 		$1.78M Hold
106,600
– – ﹤0.01% 1783
2018
Q1 		$1.66M Buy
106,600
+5,200
+5% +$92.7K ﹤0.01% 1763
2017
Q4 		$1.91M Hold
101,400
– – ﹤0.01% 1667
2017
Q3 		$2.96M Hold
101,400
– – ﹤0.01% 1364
2017
Q2 		$3.26M Hold
101,400
– – ﹤0.01% 1265
2017
Q1 		$3.51M Sell
101,400
-2,000
-2% -$71.4K ﹤0.01% 1210
2016
Q4 		$3.65M Hold
103,400
– – 0.01% 1165
2016
Q3 		$3.59M Sell
103,400
-3,500
-3% -$123K 0.01% 1129
2016
Q2 		$4M Hold
106,900
– – 0.01% 1044
2016
Q1 		$4.17M Buy
106,900
+20,400
+24% +$760K 0.01% 980
2015
Q4 		$3.11M Hold
86,500
– – 0.01% 1054
2015
Q3 		$2.76M Buy
86,500
+10,600
+14% +$361K 0.01% 1106
2015
Q2 		$2.58M Buy
75,900
+5,500
+8% +$185K 0.01% 1153
2015
Q1 		$2.38M Buy
70,400
+800
+1% +$27.9K 0.01% 1183
2014
Q4 		$2.44M Buy
69,600
+1,500
+2% +$50.5K 0.01% 1129
2014
Q3 		$2.23M Sell
68,100
-1,600
-2% -$54.4K 0.01% 1121
2014
Q2 		$2.37M Hold
69,700
– – 0.01% 1145
2014
Q1 		$2.44M Buy
69,700
+11,300
+19% +$399K 0.01% 1095
2013
Q4 		$2.13M Buy
58,400
+400
+0.7% +$14.7K 0.01% 1034
2013
Q3 		$2.01M Buy
58,000
+1,200
+2% +$42K 0.01% 1007
2013
Q2 		$1.92M Buy
+56,800
New +$1.89M 0.01% 1008

Other funds holding ACH

CCM
Coliseum Capital Management Rowayton, Connecticut $1.16B AUM 23.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $1.67B AUM 1.43% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $3.67B AUM 121.12% 1-Year Est. Return

Swiss National Bank's ACH Position: Q4 2025 in Review

Swiss National Bank sold out of Accendra Health (ACH) in Q4 2025, closing a stake of 148,500 shares — an estimated $713K sold.

Swiss National Bank first reported a position in ACH in Q2 2013 and held it in 48 quarters. The position peaked at $7.46M in Q1 2022. 168 funds tracked by Wall St. Rank hold ACH as of Q4 2025.

  • Swiss National Bank reported no remaining Accendra Health position as of Q4 2025 after selling out during the quarter.
  • Swiss National Bank sold 148,500 Accendra Health shares in Q4 2025, an estimated $713K.
  • Swiss National Bank first reported a position in Accendra Health in Q2 2013 and held it in 48 quarters.
  • Swiss National Bank's Accendra Health position peaked at $7.46M in Q1 2022.
  • 168 funds tracked by Wall St. Rank held Accendra Health as of Q4 2025.

Based on Swiss National Bank's 13F filing for Q4 2025, filed 12 Feb 2026.